COVID-19 Vaccine Clinical Trials
COVID-19 continues to affect adults of all ages, and research plays an important role in understanding how vaccines can help protect our communities. 3A Research is conducting a COVID-19 Vaccine Clinical Trial evaluating a SARS-CoV-2 recombinant spike protein vaccine in adults aged 50 to 64. Enrollment for this study is currently closed while the study is ongoing — explore what the research involves, and contact us to learn about other studies you may qualify for.
This study is no longer recruiting.
The information below is kept for reference only.
COVID-19 Vaccine Clinical Trials
Understanding the Condition
COVID-19 is a respiratory illness caused by the SARS-CoV-2 virus. Symptoms can range from mild — such as cough, fever, and fatigue — to more serious respiratory illness, and the level of risk can differ from person to person.
Vaccines are one of the tools used to help reduce the spread and impact of COVID-19. Ongoing research continues to gather information about how vaccines perform in different groups of adults over time.
By taking part in a COVID-19 Vaccine Research Study in Texas, participants contribute to a better understanding of vaccine safety and effectiveness and help inform future prevention efforts.
Important Information About Participation
Participation in COVID-19 Vaccine Clinical Trials is voluntary. Vaccines are studied for safety and effectiveness, but there is no guarantee of personal benefit. Studies are conducted under strict regulatory guidelines. Consult with your healthcare provider before enrolling in this or any other clinical research study.
- Age
- 50 to 64 Years
- Gender
- Males and Females
- Condition
- COVID-19
- Location
- Texas
About the COVID-19 Vaccine Study
This Phase 4 post-marketing study is evaluating the safety and efficacy of a SARS-CoV-2 recombinant spike protein vaccine in adults aged 50 to 64 who do not have conditions that place them at high risk for severe COVID-19. Post-marketing studies gather additional information about a vaccine after it has been approved.
Participants take part in study visits where the study team monitors their health and gathers information over the course of the study. Enrollment for this study is currently closed while the study is ongoing.
What to Expect in COVID-19 Vaccine Clinical Trials
This study is currently closed to enrollment while it is ongoing. Clinical trials give participants access to study-related care and monitoring under expert medical supervision. Contact us to learn about other studies at 3A Research that may be accepting participants.
Frequently Asked Questions
This study is closed to enrollment, but it is ongoing — participants already enrolled continue to attend their study visits. Contact us to learn about other studies at 3A Research that may be accepting participants.
A Phase 4, or post-marketing, study takes place after a vaccine has already been approved. It gathers additional information about how the vaccine performs in a broader group of people over time.
COVID-19 is caused by the SARS-CoV-2 virus and spreads mainly through respiratory droplets and small airborne particles when an infected person coughs, sneezes, talks, or breathes. Everyday preventive steps and vaccination are used to help reduce its spread.
Participants attend scheduled study visits where the study team monitors their health and collects information over the course of the study.
Contact our team. We will let you know about other clinical trials at 3A Research and help determine whether any may be a good fit for you.